Correlation analysis of serum galectin-3 combined with Th1/Th2-related cytokines and severe anxiety and depression symptoms in patients with chronic obstructive pulmonary disease.

The COVID-19 pandemic prompted a rapid national expansion of digital health. Telehealth rose from a fraction of a percent of outpatient encounters to a double-digit share of ambulatory care within weeks, health information exchanges processed record data volumes, and remote monitoring tools moved abruptly into routine use. As the emergency receded, the central question became how much of this expansion would persist, and for which populations. The answer varies by setting. Nationally, telehealth has stabilized at roughly 10% of outpatient visits, above pre-pandemic levels; hospital EHR adoption has reached 96%; federal broadband investment through the $42.5 billion BEAD program is beginning to reach states; and the 21st Century Cures Act’s information-blocking provisions and the Trusted Exchange Framework and Common Agreement (TEFCA) are reshaping health-data-sharing rules. Whether this national momentum reaches the states and populations with the greatest need is less clear. Most published literature on digital health adoption in the United States operates at the national level, using Centers for Medicare & Medicaid Services (CMS) claims or large surveys, or at the institutional level, reporting a single health system’s experience. State-level analyses that integrate policy, infrastructure, utilization, and equity within one jurisdiction remain uncommon, even though many decisions that determine whether digital health reaches a given population, including Medicaid reimbursement, telehealth licensure, HIE consent frameworks, and broadband priorities, are made at the state level.